Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Interest & Investment Income: 2015-2024

Historic Interest & Investment Income for Kura Oncology (KURA) over the last 10 years, with Dec 2024 value amounting to $22.8 million.

  • Kura Oncology's Interest & Investment Income rose 6.48% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.7 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2024, which is 55.20% up from last year.
  • According to the latest figures from FY2024, Kura Oncology's Interest & Investment Income is $22.8 million, which was up 55.20% from $14.7 million recorded in FY2023.
  • In the past 5 years, Kura Oncology's Interest & Investment Income ranged from a high of $22.8 million in FY2024 and a low of $1.2 million during FY2021.
  • Its 3-year average for Interest & Investment Income is $13.9 million, with a median of $14.7 million in 2023.
  • In the last 5 years, Kura Oncology's Interest & Investment Income slumped by 57.71% in 2021 and then soared by 252.74% in 2022.
  • Kura Oncology's Interest & Investment Income (Yearly) stood at $2.9 million in 2020, then plummeted by 57.71% to $1.2 million in 2021, then soared by 252.74% to $4.3 million in 2022, then skyrocketed by 246.07% to $14.7 million in 2023, then skyrocketed by 55.20% to $22.8 million in 2024.